Limen Recovery

The short picture on Limen Recovery (Wilmington, DE): The facility offers a continuum of care across multiple levels — Inpatient, Outpatient, MAT, Dual Dx — which means it can, in principle, hold a patient across the arc of a typical treatment episode. The longer picture — clinical framework, payer mix, outcomes — takes a few specific questions to surface.

Care levels at Limen Recovery

The facility offers a continuum of care across multiple levels — Inpatient, Outpatient, MAT, Dual Dx — which means it can, in principle, hold a patient across the arc of a typical treatment episode. The practical question is whether it is genuinely strong at each level, or whether one level is the core business and the others are secondary. The level-of-care question is where a lot of misaligned placements happen — a patient who needs residential ends up in IOP, or vice versa. The protection is a clinical assessment outside the facility's admissions team.

Insurance and payment

Limen Recovery accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. Most post-treatment billing disputes trace back to a specific moment when an admissions counselor said one thing and the benefits department later documented something else. Avoid the moment by getting the written VOB before admission, not after.

Specialty programming

The facility's documented specialty programming includes: Seniors or older adults, Veterans, Members of military families. A facility's specialty designation is a starting filter, not an endorsement. The operational questions (who leads it, how many hours per week, what credentials) are where the actual answer lives.

Before you call

Questions that matter before admitting to Limen Recovery: ASAM level of care (not the facility's category, the clinical level); written VOB; MAT policy. The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation. The ones who answer those quickly are usually the ones worth considering. The ones who dodge are almost always worth skipping.